Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from IMARA

Robin Hood Half Marathon announces charity partners and urges runners to raise 'vital' funds

The organisers of September’s Robin Hood Marathon Events weekend have announced they are working with even more charities than ever this year

Nottingham Post · May 31, 2023

$1.9 Million Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying

The Dow Jones dropped by around 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment…

Benzinga · Oct 20, 2022

Why IMARA Shares Are Trading Higher By Over 13%; Here Are 22 Stocks Moving Premarket

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares rose 80.1% to $0.4161 in pre-market trading after declining around 7% on Thursday. CONNEXA, last month, announced a $5.0 million private placement.

Benzinga · Oct 14, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

4 Stocks Under $2 Insiders Are Aggressively Buying

US stock futures traded lower this morning ahead of the release of big tech earnings. Investors, meanwhile, focused on some notable insider trades.

Benzinga · Apr 26, 2022

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga · Apr 18, 2022

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga · Apr 5, 2022

Read Why Imara Shares Are Falling Today

Imara Inc (NASDAQ:IMRA) shares are falling after interim analyses of its Ardent Phase 2b trial of tovinontrine (IMR-687) in sickle cell disease (SCD) and Forte Phase 2b trial in beta-thalassemia. Data from the sickle cell disease study interim analysis demonstrated that tovinontrine was generally well-tolerated. Four (3.6%) participants discontinued before week 24 due…

Benzinga · Apr 5, 2022

Read news from The Economist, FT, and more,
with one subscription

Coverage From

Organisations

Nottingham University Hospitals NHS Trust

TRACON Pharmaceuticals

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.